MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss for the
period
-$2,028,223
Sales
$820,188
Loss before income
taxes
-$2,028,223
Interest and other income
$74,379
Gross profit
$184,194
Cost of sales
$635,994
Total operating
expenses
$2,286,796
Foreign exchange loss
(gain)
$18,136
Amortization and
depreciation
$53,201
General and
administrative
$1,621,095
Research and development
$630,636
Back
Back
Income Statement
source: myfinsight.com
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)